Estrogen and insulin synergistically promote type 1 endometrial cancer progression

Reference

• Allen NE, Key TJ, Dossus L, Rinaldi S, Cust A, Lukanova A, Peeters PH, Onland-Moret NC, Lahmann PH, Berrino F, Panico S, Larranaga N, Pera G, Tormo MJ, Sanchez MJ, Ramon Quiros J, Ardanaz E, Tjonneland A, Olsen A, Chang-Claude J, Linseisen J, Schulz M, Boeing H, Lundin E, Palli D, Overvad K, Clavel-Chapelon F, Boutron-Ruault MC, Bingham S, Khaw KT, Bueno-de-Mesquita HB, Trichopoulou A, Trichopoulos D, Naska A, Tumino R, Riboli E, Kaaks R. ‘Endogenous sex hormones and endometrial cancer risk in women in the european prospective investigation into cancer and nutrition (Epic)’. Endocr Relat Cancer. 2008;15:485–97. doi:10.1677/ERC-07-0064.
   PubMed Web of Science ®Google Scholar
• Bokhman JV. ‘Two pathogenetic types of endometrial Carcinoma’. Gynecol Oncol. 1983;15:10–7. doi:10.1016/0090-8258(83)90111-7.
   PubMed Web of Science ®Google Scholar
• Bradley LM, Gierthy JF, Pentecost BT. ‘Role of the insulin-like growth factor system on an estrogen-dependent cancer phenotype in the Mcf-7 human breast cancer cell line’. J Steroid Biochem Mol Biol. 2008;109:185–96. doi:10.1016/j.jsbmb.2007.10.006.
   PubMed Web of Science ®Google Scholar
• Brown SB, Hankinson SE. ‘Endogenous estrogens and the risk of Breast, Endometrial, and Ovarian Cancers’. Steroids. 2015;99:8–10. doi:10.1016/j.steroids.2014.12.013.
   PubMed Web of Science ®Google Scholar
• Chen W, Zheng R, Baade PD, Zhang S, Zeng H, Bray F, Jemal A, Yu XQ, He J, ‘Cancer Statistics in China, 2015’. CA Cancer J Clin. 2016;66:115–32. doi:10.3322/caac.21338.
   PubMed Web of Science ®Google Scholar
• Diamanti-Kandarakis E, Papailiou J, Palimeri S, ‘Hyperandrogenemia: Pathophysiology and its role in ovulatory dysfunction in Pcos’. Pediatr Endocrinol Rev. 2006;3 Suppl 1:198–204.
   PubMedGoogle Scholar
• Hapangama DK, Kamal AM, Bulmer JN. ‘Estrogen receptor beta: The guardian of the Endometrium’. Hum Reprod Update. 2015;21:174–93. doi:10.1093/humupd/dmu053.
   PubMed Web of Science ®Google Scholar
• Joung KH, Jeong JW, Ku BJ. ‘The association between Type 2 diabetes mellitus and Women Cancer: The epidemiological evidences and putative mechanisms’. Biomed Res Int. 2015;2015:920618.
   PubMedGoogle Scholar
• Kamal A, Tempest N, Parkes C, Alnafakh R, Makrydima S, Adishesh M, Hapangama DK. ‘Hormones and endometrial Carcinogenesis’. Horm Mol Biol Clin Investig. 2016;25:129–48.
   PubMed Web of Science ®Google Scholar
• Kurita T, Wang YZ, Donjacour AA, Zhao C, Lydon JP, O'Malley BW, Isaacs JT, Dahiya R, Cunha GR. ‘Paracrine regulation of apoptosis by steroid hormones in the Male and Female reproductive system’. Cell Death Differ. 2001;8:192–200. doi:10.1038/sj.cdd.4400797.
   PubMed Web of Science ®Google Scholar
• Li Q, Kannan A, DeMayo FJ, Lydon JP, Cooke PS, Yamagishi H, Srivastava D, Bagchi MK, Bagchi IC. ‘The Antiproliferative action of progesterone in uterine epithelium is mediated by Hand2’. Science. 2011;331:912–6. doi:10.1126/science.1197454.
   PubMed Web of Science ®Google Scholar
• Mathew D, Drury JA, Valentijn AJ, Vasieva O, Hapangama DK. ‘In Silico, in Vitro and in Vivo analysis identifies a potential role for Steroid hormone regulation of Foxd3 in Endometriosis-Associated genes’. Hum Reprod. 2016;31:345–54.
   PubMed Web of Science ®Google Scholar
• Meng YG, Han WD, Zhao YL, Huang K, Si YL, Wu ZQ, Mu YM, ‘Induction of the Lrp16 Gene by estrogen promotes the invasive growth of Ishikawa human endometrial Cancer cells through the downregulation of E-Cadherin’. Cell Res. 2007;17:869–80. doi:10.1038/cr.2007.79.
   PubMed Web of Science ®Google Scholar
• Mu N, Zhu Y, Wang Y, Zhang H, Xue F. ‘Insulin resistance: A significant risk factor of Endometrial Cancer’. Gynecol Oncol. 2012;125:751–7. doi:10.1016/j.ygyno.2012.03.032.
   PubMed Web of Science ®Google Scholar
• Plymate SR, Matej LA, Jones RE, Friedl KE. ‘Inhibition of Sex hormone-binding globulin production in the Human Hepatoma (Hep G2) Cell line by Insulin and Prolactin’. J Clin Endocrinol Metab. 1988;67:460–4. doi:10.1210/jcem-67-3-460.
   PubMed Web of Science ®Google Scholar
• Schindler AE. ‘Progestogen deficiency and endometrial Cancer Risk’. Maturitas. 2009;62:334–7. doi:10.1016/j.maturitas.2008.12.018.
   PubMed Web of Science ®Google Scholar
• Setiawan VW, Yang HP, Pike MC, McCann SE, Yu H, Xiang YB, Wolk A, Wentzensen N, Weiss NS, Webb PM, van den Brandt PA, van de Vijver K, Thompson PJ, Group Australian National Endometrial Cancer Study, Strom BL, Spurdle AB, Soslow RA, Shu XO, Schairer C, Sacerdote C, Rohan TE, Robien K, Risch HA, Ricceri F, Rebbeck TR, Rastogi R, Prescott J, Polidoro S, Park Y, Olson SH, Moysich KB, Miller AB, McCullough ML, Matsuno RK, Magliocco AM, Lurie G, Lu L, Lissowska J, Liang X, Lacey JV, Jr., Kolonel LN, Henderson BE, Hankinson SE, Hakansson N, Goodman MT, Gaudet MM, Garcia-Closas M, Friedenreich CM, Freudenheim JL, Doherty J, De Vivo I, Courneya KS, Cook LS, Chen C, Cerhan JR, Cai H, Brinton LA, Bernstein L, Anderson KE, Anton-Culver H, Schouten LJ, Horn-Ross PL. ‘Type I and Ii Endometrial Cancers: Have they different risk factors?’. J Clin Oncol. 2013;31:2607–18. doi:10.1200/JCO.2012.48.2596.
   PubMed Web of Science ®Google Scholar
• Shao R, Li X, Feng Y, Lin JF, Billig H. ‘Direct effects of Metformin in the Endometrium: A hypothetical mechanism for the treatment of Women with Pcos and Endometrial Carcinoma’. J Exp Clin Cancer Res. 2014;33:41. doi:10.1186/1756-9966-33-41.
   PubMed Web of Science ®Google Scholar
• Siegel RL, Miller KD, Jemal A. ‘Cancer Statistics, 2016’. CA Cancer J Clin. 2016;66:7–30. doi:10.3322/caac.21332.
   PubMed Web of Science ®Google Scholar
• Suba Z. ‘Interplay between insulin resistance and Estrogen deficiency as Co- Activators in Carcinogenesis’. Pathology & Oncology Research. 2012;18:123–33. doi:10.1007/s12253-011-9466-8.
   PubMed Web of Science ®Google Scholar
• Tian W, Zhu Y, Wang Y, Teng F, Zhang H, Liu G, Ma X, Sun D, Rohan T, Xue F. ‘Visfatin, A potential biomarker and prognostic factor for endometrial Cancer’. Gynecol Oncol. 2013;129:505–12. doi:10.1016/j.ygyno.2013.02.022.
   PubMed Web of Science ®Google Scholar
• Vermeulen A, Verdonck L. ‘Sex Hormone concentrations in post-menopausal women’. Clin Endocrinol (Oxf). 1978;9:59–66.
   PubMedGoogle Scholar
• Wang Y, Hua S, Tian W, Zhang L, Zhao J, Zhang H, Zhang W, Xue F. ‘Mitogenic and anti-apoptotic effects of insulin in endometrial cancer are Phosphatidylinositol 3-Kinase/Akt Dependent’. Gynecol Oncol. 2012;125:734–41. doi:10.1016/j.ygyno.2012.03.012.
   PubMed Web of Science ®Google Scholar
• Wang Y, Zhu Y, Zhang L, Tian W, Hua S, Zhao J, Zhang H, Xue F. ‘Insulin promotes proliferation, Survival, and Invasion in Endometrial Carcinoma by Activating the Mek/Erk Pathway’. Cancer Lett. 2012;322:223–31. doi:10.1016/j.canlet.2012.03.026.
   PubMed Web of Science ®Google Scholar
• Wu MH, Chou YC, Chou WY, Hsu GC, Chu CH, Yu CP, Yu JC, Sun CA. ‘Relationships between critical period of Estrogen exposure and circulating levels of Insulin-Like Growth Factor-I (Igf-I) in Breast Cancer: Evidence from a case-control study’. Int J Cancer. 2010;126:508–14. doi:10.1002/ijc.24722.
   PubMed Web of Science ®Google Scholar